Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Director bought 2,000 shares at $5.75 ($11,500)
  2. 4 Open-market buy Director bought 1,500 shares at $5.63 ($8,445)
  3. 4 Open-market buy Director bought 5,548 shares at $5.71 ($31,679)
  4. 4 Open-market buy Director bought 7,000 shares at an average $5.47 ($38,300)
  5. 4 Open-market buy President and CEO bought 5,000 shares at $5.77 ($28,850)
  6. 4 Open-market buy Director bought 5,000 shares at $5.69 ($28,450)
  7. 4 Open-market buy Director bought 1,500 shares at $5.99 ($8,985)
  8. 4 Open-market buy Director bought 2,000 shares at an average $5.41 ($10,820)
  9. 4 Open-market buy Director bought 4,400 shares at an average $5.46 ($24,034)
  10. 4 Open-market buy Director bought 9,400 shares at an average $5.46 ($51,320)
  11. 4 Open-market buy President and CEO bought 200 shares at $4.00 ($800)
  12. 4 Open-market buy Director bought 6,500 shares at $3.62 ($23,530)
  13. 4 Open-market buy President and CEO bought 200 shares at $3.80 ($760)
  14. 4 Open-market buy Director bought 3,500 shares at $3.94 ($13,790)
  15. 4 Open-market buy Director bought 1,700 shares at $3.98 ($6,766)
  16. 4 Open-market buy President and CEO bought 1,100 shares at an average $3.84 ($4,225)
  17. 4 Open-market buy President and CEO bought 1,712 shares at an average $4.24 ($7,258)
  18. 4 Open-market buy Director bought 2,000 shares at $3.95 ($7,900)
  19. 4 Open-market buy Director bought 6,000 shares at $3.95 ($23,700)
  20. 4 Open-market buy Director bought 100 shares at $8.95 ($895)

Page 14 of 24 · 471 filings